# Treatment of Cryptosporidiosis

> **NCT04103216** · NA · COMPLETED · sponsor: **International Centre for Diarrhoeal Disease Research, Bangladesh** · enrollment: 64 (actual)

## Conditions studied

- Cryptosporidiosis

## Interventions

- **OTHER:** Nitazoxanide with Lactobacillus Reuteri DSM 17938
- **OTHER:** Nitazoxanide

## Key facts

- **NCT ID:** NCT04103216
- **Lead sponsor:** International Centre for Diarrhoeal Disease Research, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2023-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04103216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04103216, "Treatment of Cryptosporidiosis". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04103216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*